Crossref journal-article
American Association for the Advancement of Science (AAAS)
Science (221)
Abstract

GADS is an adaptor protein implicated in CD3 signaling because of its ability to link SLP-76 to LAT. A GADS-deficient mouse was generated by gene targeting, and the function of GADS in T cell development and activation was examined. GADS – CD4 – CD8 – thymocytes exhibited a severe block in proliferation but still differentiated into mature T cells. GADS – thymocytes failed to respond to CD3 cross-linking in vivo and were impaired in positive and negative selection. Immunoprecipitation experiments revealed that the association between SLP-76 and LAT was uncoupled in GADS – thymocytes. These observations indicate that GADS is a critical adaptor for CD3 signaling.

Bibliography

Yoder, J., Pham, C., Iizuka, Y.-M., Kanagawa, O., Liu, S. K., McGlade, J., & Cheng, A. M. (2001). Requirement for the SLP-76 Adaptor GADS in T Cell Development. Science, 291(5510), 1987–1991.

Authors 7
  1. Jeff Yoder (first)
  2. Christine Pham (additional)
  3. Yoshie-Matsubayashi Iizuka (additional)
  4. Osami Kanagawa (additional)
  5. Stanley K. Liu (additional)
  6. Jane McGlade (additional)
  7. Alec M. Cheng (additional)
References 29 Referenced 122
  1. Chan A. C., Shaw A. S., Curr. Opin. Immunol. 8, 394 (1996). (10.1016/S0952-7915(96)80130-0) / Curr. Opin. Immunol. by Chan A. C. (1996)
  2. J. Bubeck Wardenburg et al. Immunity 9 607 (1998). (10.1016/S1074-7613(00)80658-5)
  3. S. C. Bunnell et al. J. Biol. Chem. 275 2219 (2000). (10.1074/jbc.275.3.2219)
  4. J. K. Jackman et al. J. Biol. Chem. 270 7029 (1995). (10.1074/jbc.270.13.7029)
  5. 10.1016/S0092-8674(00)80901-0
  6. J. L. Clements et al. Science 281 416 (1998). (10.1126/science.281.5375.416)
  7. V. Pivniouk et al. Cell 94 229 (1998). (10.1016/S0092-8674(00)81422-1)
  8. W. Zhang et al. Immunity 10 323 (1999). (10.1016/S1074-7613(00)80032-1)
  9. H. Asada et al. J. Exp. Med. 189 1383 (1999). (10.1090/conm/242/03669)
  10. R. P. Bourette et al. EMBO J. 17 7273 (1998). (10.1093/emboj/17.24.7273)
  11. C. L. Law et al. J. Exp. Med. 189 1243 (1999).
  12. Liu S. K., McGlade C. J., Oncogene 17, 3073 (1998). (10.1038/sj.onc.1202337) / Oncogene by Liu S. K. (1998)
  13. Liu S. K., Fang N., Koretzky G. A., McGlade C. J., Curr. Biol. 9, 67 (1999). (10.1016/S0960-9822(99)80017-7) / Curr. Biol. by Liu S. K. (1999)
  14. Zhang W., Irvin B. J., Trible R. P., Abraham R. T., Samelson L. E., Int. Immunol. 11, 943 (1999). (10.1093/intimm/11.6.943) / Int. Immunol. by Zhang W. (1999)
  15. Finco T. S., Kadlecek T., Zhang W., Samelson L. E., Weiss A., Immunity 9, 617 (1998). (10.1016/S1074-7613(00)80659-7) / Immunity by Finco T. S. (1998)
  16. S. Saitoh et al. Immunity 12 525 (2000). (10.1016/S1074-7613(00)80204-6)
  17. Supplementary information is available at www.sciencemag.org/cgi/content/full/291/5510/1987/DC1.
  18. J. L. Clements et al. J. Clin. Invest. 103 19 (1999). (10.1172/JCI5317)
  19. Rodewald H. R., Fehling H. J., Adv. Immunol. 69, 1 (1998). (10.1016/S0065-2776(08)60606-9) / Adv. Immunol. by Rodewald H. R. (1998)
  20. 10.1038/375795a0
  21. E. S. Hoffman et al. Genes Dev. 10 948 (1996). (10.1101/gad.10.8.948)
  22. Shinkai Y., Alt F. W., Int. Immunol. 6, 995 (1994). (10.1093/intimm/6.7.995) / Int. Immunol. by Shinkai Y. (1994)
  23. Levelt C. N., Ehrfeld A., Eichmann K., J. Exp. Med. 177, 707 (1993). (10.1084/jem.177.3.707) / J. Exp. Med. by Levelt C. N. (1993)
  24. Kisielow P., Bluthmann H., Staerz U. D., Steinmetz M., von Boehmer H., Nature 333, 742 (1988). (10.1038/333742a0) / Nature by Kisielow P. (1988)
  25. Unpublished results.
  26. E. M. Schaeffer et al. Science 284 638 (1999). (10.1126/science.284.5414.638)
  27. Sharp L. L., Schwarz D. A., Bott C. M., Marshall C. J., Hedrick S. M., Immunity 7, 609 (1997). (10.1016/S1074-7613(00)80382-9) / Immunity by Sharp L. L. (1997)
  28. J. O. Ebinu et al. Science 280 1082 (1998). (10.1126/science.280.5366.1082)
  29. Thymic DN cells were purified by Dynal magnetic beads. Purified samples were stained with antibody to CD25-FITC washed and fixed in 70% ethanol. Cells were washed and treated with propidium iodide (10 mg/ml) and ribonuclease A (250 mg/ml). Cells were gated for singlets and CD25 + and DNA content was determined by FL2-H. 30 .  We thank A. C. Chan and laboratory for many suggestions technical advice and generous gifts of reagents and the Dr. Hector Molina laboratory for help and support. Supported by a research startup fund provided by the Department of Medicine and the Department of Pathology and Immunology at the Washington University School of Medicine.
Dates
Type When
Created 23 years, 1 month ago (July 27, 2002, 5:48 a.m.)
Deposited 1 year, 7 months ago (Jan. 9, 2024, 6:06 p.m.)
Indexed 2 months ago (July 2, 2025, 6:01 p.m.)
Issued 24 years, 5 months ago (March 9, 2001)
Published 24 years, 5 months ago (March 9, 2001)
Published Print 24 years, 5 months ago (March 9, 2001)
Funders 0

None

@article{Yoder_2001, title={Requirement for the SLP-76 Adaptor GADS in T Cell Development}, volume={291}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.1057176}, DOI={10.1126/science.1057176}, number={5510}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Yoder, Jeff and Pham, Christine and Iizuka, Yoshie-Matsubayashi and Kanagawa, Osami and Liu, Stanley K. and McGlade, Jane and Cheng, Alec M.}, year={2001}, month=mar, pages={1987–1991} }